Healius Limited (ASX: HLS) currently maintains a dividend yield of 0.00 percent, reflecting capital management strategies and corporate restructuring phases where executive leadership and the board suspended regular dividend distributions to prioritize balance sheet optimization, debt reduction, and operational turnaround initiatives across its core pathology and diagnostic imaging divisions.